Correlation Between Y MAbs and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Y MAbs and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Y MAbs and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Y mAbs Therapeutics and Travere Therapeutics, you can compare the effects of market volatilities on Y MAbs and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Y MAbs with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Y MAbs and Travere Therapeutics.
Diversification Opportunities for Y MAbs and Travere Therapeutics
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between YMAB and Travere is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Y mAbs Therapeutics and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Y MAbs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Y mAbs Therapeutics are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Y MAbs i.e., Y MAbs and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Y MAbs and Travere Therapeutics
Given the investment horizon of 90 days Y mAbs Therapeutics is expected to under-perform the Travere Therapeutics. In addition to that, Y MAbs is 1.36 times more volatile than Travere Therapeutics. It trades about -0.19 of its total potential returns per unit of risk. Travere Therapeutics is currently generating about 0.08 per unit of volatility. If you would invest 1,776 in Travere Therapeutics on August 31, 2024 and sell it today you would earn a total of 94.00 from holding Travere Therapeutics or generate 5.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Y mAbs Therapeutics vs. Travere Therapeutics
Performance |
| Timeline |
| Y mAbs Therapeutics |
| Travere Therapeutics |
Y MAbs and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Y MAbs and Travere Therapeutics
The main advantage of trading using opposite Y MAbs and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Y MAbs position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Y MAbs vs. Revolution Medicines | Y MAbs vs. Black Diamond Therapeutics | Y MAbs vs. Passage Bio | Y MAbs vs. Bluebird bio |
| Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |